Monoclonal antibody monitoring: clinically relevant aspects, a systematic critical review
M Regazzi, J Golay, M Molinaro - Therapeutic Drug Monitoring, 2020 - journals.lww.com
Monoclonal antibody (mAb) therapy does not usually lead to a clinical response in all
patients and resistance may increase over time after repeated mAb administration. This lack …
patients and resistance may increase over time after repeated mAb administration. This lack …
Monoclonal Antibody Monitoring: Clinically Relevant Aspects, A Systematic Critical Review
M Regazzi, J Golay, M Molinaro - Therapeutic drug …, 2020 - pubmed.ncbi.nlm.nih.gov
Monoclonal antibody (mAb) therapy does not usually lead to a clinical response in all
patients and resistance may increase over time after repeated mAb administration. This lack …
patients and resistance may increase over time after repeated mAb administration. This lack …
Monoclonal Antibody Monitoring: Clinically Relevant Aspects, A Systematic Critical Review.
M Regazzi, J Golay, M Molinaro - Therapeutic Drug Monitoring, 2020 - europepmc.org
Monoclonal antibody (mAb) therapy does not usually lead to a clinical response in all
patients and resistance may increase over time after repeated mAb administration. This lack …
patients and resistance may increase over time after repeated mAb administration. This lack …